April 15, 2021

BirchBioMed Welcomes Dr. Jonathan Bourne as new Chief Science Officer

March 2021

Innovation in Treatment of Keloid Scars

“Topical FS2 for Mature Keloid Scars”

Mark Steven Nestor, M.D., Ph.D.
Director
Center for Cosmetic Enhancement, Center for Clinical and Cosmetic Research, Aventura Florida
Voluntary Professor
Department of Dermatology and Cutaneous Surgery
Department of Surgery, Division of Plastic Surgery
University of Miami Miller School of Medicine

January 21, 2021

Positive Topline Data from Phase 2 Study of FS2 for Treatment of Keloid Scars

November 4, 2020

BirchBioMed appoints pharmaceutical leader and global affairs expert to its Board of Directors …

March 25, 2020

BirchBioMed welcomes renowned dermatologist to its board of directors …

December 9, 2019

BirchBioMed enrolls first patient in phase II clinical trial of its unique treatment to prevent scarring

March 28, 2019

Birch Issues Letter to Shareholders

February 28, 2019

First Patient Enrolled in BirchBioMed’s Study Investigating FS2 for the Treatment of Scars

February 5, 2019

BirchBioMed to Highlight FS2 Platform at the 17th Annual South Beach Symposium
Management also to host a collaborative advisory board

November 29, 2018

BirchBioMed, Inc. to Present at the 11th Annual LD Micro Main Event

November 29, 2018

BirchBioMed, Inc. to Present at the 11th Annual LD Micro Main Event

August 13, 2018

Sensus Healthcare CEO Joseph C. Sardano Joins BirchBioMed Inc. Board of Directors

May 10, 2018

Chief Science Officer, Dr. Ryan Hartwell, lecture at South Beach Symposium on the latest discoveries and innovations in fibrosis research, notably highlighting published data from BirchBioMed and the University of British Columbia.

April 9, 2018

Q&A with Mark S. Miller, Co-founder, Chairman and CEO of BirchBioMed Inc. developing an Antifibrotic Therapeutic for the Prevention of Scaring and Breaking Down Existing Scars and an Autoimmune Platform for reversing Type l Diabetes

March 3, 2018

Chairman & CEO, Mark Miller remarks delivered at CEO Forum at South Beach Symposium on “Innovation in an Era of Healthcare Upheaval”

February 17, 2018

Birchbiomed Is Cleared To Begin First-of-its-kind Phase II Clinical Trial For Ground-Breaking Anti-Scarring Drug

February 5, 2018

Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World

July 25, 2017

BirchBioMed’s Scientific Advisory Board Member Dr. Aziz Ghahary is the 2017 British Columbia Professional Fire Fighters Burn Fund Honouree

August 25, 2016

Birchbiomed announces completion of clinical trial For ground-breaking anti-scarring drug

September 1, 2015

UBC Develops Anti-scarring Drug

September 1, 2015

CKNW – Sean Leslie Show – Fibrostop, a Drug to Help Burn Victims

August 28, 2015

UBC researchers develop drug to treat scarring and autoimmune diseases…